Clinical Trial Update: Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (GXCPC1) for Knee Osteoarthritis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of allogeneic adipose tissue-derived mesenchymal stem cells (GXCPC1) for knee osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• GXCPC1

Snippet

Sponsor: Gwo Xi Stem Cell Applied Technology Co., Ltd. | Conditions: Knee Osteoarthritis | Phase 1, Phase 2 | Status: COMPLETED